Looking the stock over . . . is not Mr. Frost's age quite advanced to be actively running such a company?
The Claros I in-office patient sample testing system seems well set-up for2018 approval. What about other mobile testing methods competitors like devices, that attach to cell phones and tablets that are developing and use apps and cloud to process patient test results and are send to the doctor?
Really . . . is Mr. Frost the major funder of this company finances (along with his money partners)? Is he really that rich?
OPK website stated the company also is conducting numerous investments in other medical tech companies . . . I should hope some of them would be fruitful for OPK.
Who do you think is 'beating down' this stock price . . . is it just necessary adjustments in funds EOY tax-selling positioning?
With 6K employees . . . is not that a lot of pay-rolling and marketing costs to incur?
News 
Market Data 
Discover 
